Global Next Generation Cancer Diagnostics Market By Product Type (Liquid Biopsy, Genetic Testing, Next Generation Sequencing, Immunoassays, and Radiomics), By Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Leukemia), By End-user (Hospitals, Research Institutions, Laboratories, and Diagnostic Centers), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Feb 2025
- Report ID: 140727
- Number of Pages: 235
- Format:
-
-
-
- Thermo Fisher Scientific Company Profile
- QIAGEN NV Company Profile
- Novartis AG Company Profile
- Illumina, Inc
- GE HealthCare
- Hoffmann-La Roche Ltd
- Agilent Technologies, Inc
- Abbott Laboratories
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible